Pharmagest Interactive: H1 2021 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH GILBERT DUPONT

Villers-lès-Nancy, 21 July 2021 - 6:00 p.m. (CET)

PRESS RELEASE
For immediate release

H1 2021 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT
WITH THE BROKERAGE FIRM GILBERT DUPONT

Under the liquidity agreement administered by the brokerage firm, Gilbert Dupont, on behalf of PHARMAGEST INTERACTIVE, liquidity account holdings at 30 June 2021 were as follows:

- Number of shares: 2,793
- Cash balance: €161,684.90

For the 2021 first half, a summary of total transactions is provided below:

PURCHASES	52,868 shares	€5,278,077.35	2,275 transactions
SALES	51,774 shares	€5,155,899.07	2,544 transactions

For information. liquidity account holdings were reported as follows:
in the half-year report of 31 December 2020:

- Number of shares: 1,699
- Cash balance: €283,863.20

when the liquidity agreement was first implemented:

- Number of shares: 2,219
- Cash balance: €50,000.00

This liquidity agreement is executed in accordance with decision No. 2018-01 of 2 July 2018 of the Autorité des Marchés Financiers (“AMF”) establishing accepted market practices in relation to liquidity agreements for shares.

About Pharmagest Group:

With more than 1.100 employees acting as “Citizens in the Service of Health and Well-Being”, Pharmagest Group is the leading provider of IT solutions for the healthcare sector in Europe through innovative solutions and services for healthcare professionals guaranteeing the efficiency of the healthcare system and improving the patient care pathway.

As a key contributor to the quality of healthcare and coordination between office-based private practice and hospitals, Pharmagest Group is present in France, Italy, Belgium, Luxembourg and the United Kingdom where it is developing the leading healthcare platform and a single ecosystem for France and Europe bringing the best of technology to the service of people.

Listed on Euronext Paris™ - Compartment B
Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2019 - CAC^® SMALL and CAC^® All-Tradable

Included under the European Rising Tech label

Eligible for the “long-only” Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: - PMGI FP

For all the latest news go to www.pharmagest.com

Follow Pharmagest on Twitter: @Pharmagest. LinkedIn and Facebook

CONTACTS

Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves SAMSON
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@lacooperativewelcoop.com

Media Relations:
FIN’EXTENSO - Isabelle APRILE

Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr

APPENDIX

	Purchases			Sales
	Number of transactions	Number of shares	Amounts in EUR	Number of transactions	Number of shares	Amounts in EUR
TOTAL	2,275	52,868	5,278,077.35	2,544	51,774	5,155,899.07
04/01/2021	7	120	13462	19	265	29810.01
05/01/2021	4	66	7502	10	122	13952.01
06/01/2021	6	114	13000	0	0	0
07/01/2021	15	251	28366.99	4	60	6822
08/01/2021	5	130	14748.01	16	211	24016.59
11/01/2021	18	560	63644	26	256	29109.99
12/01/2021	9	180	20507.99	48	564	64566.38
13/01/2021	28	595	68119.82	31	533	61183.6
14/01/2021	15	319	36705.38	43	697	80755.4
15/01/2021	36	459	53432.6	42	628	73523.98
18/01/2021	10	93	11048.8	21	215	25571
19/01/2021	5	175	20869.99	20	326	39316.61
20/01/2021	0	0	0	4	61	7532
21/01/2021	15	244	29278.19	4	20	2468
22/01/2021	48	993	118079.02	16	137	16445.8
25/01/2021	16	373	43318.99	9	155	18142.01
26/01/2021	1	1	115	16	277	32443.6
27/01/2021	24	529	60306	9	115	13236.99
28/01/2021	22	368	40104.01	27	369	41242.98
29/01/2021	3	100	11180	18	345	39049.41
01/02/2021	7	101	11594.8	16	332	38644.8
02/02/2021	6	154	18192	25	429	50699.39
03/02/2021	1	50	5920	27	388	46427.19
04/02/2021	53	1146	136049.22	20	274	32683.6
05/02/2021	58	1213	140881.22	8	180	20876
08/02/2021	6	170	19254	13	254	28932
09/02/2021	13	265	29897.01	16	177	20021.8
10/02/2021	17	386	43492.59	21	340	38470.39
11/02/2021	25	556	61743.58	16	271	30118.8
12/02/2021	41	672	71610.4	32	496	52707.59
15/02/2021	0	0	0	73	1270	138207.62
16/02/2021	37	728	80746.63	2	26	2896.4
17/02/2021	37	904	91128.99	35	752	76382.6
18/02/2021	22	500	51073.6	27	460	47583.41
19/02/2021	26	612	61563.1	18	469	46939.58
22/02/2021	20	337	33365.9	11	203	20272.21
23/02/2021	26	375	36582.41	35	718	70741.38
24/02/2021	44	834	82517.63	43	739	73920.4
25/02/2021	21	425	42477.01	38	691	69591.78
26/02/2021	33	820	80516.78	16	434	42696.92
01/03/2021	28	570	56521.6	21	810	80792.24
02/03/2021	40	1035	101902.68	20	442	43820.32
03/03/2021	30	438	42132.01	25	336	32459.01
04/03/2021	20	260	24265.49	18	319	29561.32
05/03/2021	6	100	9205	26	507	47494.49
08/03/2021	38	690	64054.29	22	532	50264.48
09/03/2021	0	0	0	44	786	74269.22
10/03/2021	7	231	22299.19	32	523	50833.3
11/03/2021	27	577	55903.28	22	319	31069.29
12/03/2021	35	778	74855.11	3	61	5926.4
15/03/2021	0	0	0	73	1315	128629.62
16/03/2021	24	905	89227.93	46	670	66441.89
17/03/2021	16	588	57383.98	9	134	13196.4
18/03/2021	11	255	24691.5	18	308	29991.41
19/03/2021	33	930	89549.7	49	924	89333.06
22/03/2021	31	701	67850.91	31	772	74843.08
23/03/2021	0	642	62097.19	0	723	70132.08
24/03/2021	32	891	85885.27	7	400	38820
25/03/2021	25	700	66519.53	12	248	23566
26/03/2021	10	390	37109.51	29	833	79897.69
29/03/2021	1	2	196.2	52	1091	106541.39
30/03/2021	31	809	78753.88	9	123	12091.5
31/03/2021	31	874	84094.97	9	188	18239.2
01/04/2021	4	63	6136.2	47	1632	159102.7
06/04/2021	4	50	4970	19	286	28440.1
07/04/2021	19	396	39093.2	19	240	23791.99
08/04/2021	21	417	41041.01	6	94	9312.6
09/04/2021	14	480	47040	12	232	22837.2
12/04/2021	0	0	0	43	659	65242.58
13/04/2021	5	180	17924.99	21	430	42895.98
14/04/2021	48	1465	144904.77	6	225	22511
15/04/2021	6	140	13769.99	20	350	34532.02
16/04/2021	8	364	35950.39	46	1118	111651.87
19/04/2021	11	330	33864.01	19	493	50756.42
20/04/2021	45	1070	107875.05	0	0	0
21/04/2021	23	529	52079.68	21	539	53270.88
22/04/2021	0	0	0	42	819	82505.81
23/04/2021	26	705	70945.07	25	484	48867.59
26/04/2021	31	921	92316.8	22	440	44342.19
27/04/2021	20	608	60729.23	19	415	41740.99
28/04/2021	36	707	70218.67	12	418	41583.52
29/04/2021	9	258	25508.1	11	309	30770.41
30/04/2021	1	15	1482	21	411	40699.6
03/05/2021	23	752	73796.47	11	217	21334.4
04/05/2021	32	693	67106.31	3	175	17066.51
05/05/2021	0	0	0	43	786	76253
06/05/2021	40	757	72715.53	5	66	6416.4
07/05/2021	36	636	59856.19	14	357	33715.79
10/05/2021	0	275	25580.01	0	700	66231.69
11/05/2021	18	440	40263.61	20	435	39829.51
12/05/2021	27	511	46367.48	5	25	2307.5
13/05/2021	3	165	14914.5	35	921	83779.87
14/05/2021	23	431	39049.12	31	523	47566.12
17/05/2021	15	495	44958.52	14	434	39536.18
18/05/2021	6	335	30460.51	18	528	48231.8
19/05/2021	27	677	61307.29	4	101	9150
20/05/2021	2	30	2725	27	742	67652
21/05/2021	12	274	25190.49	25	498	45901.81
24/05/2021	15	270	24611.09	14	196	17916.11
25/05/2021	26	429	38638.91	0	0	0
26/05/2021	5	70	6241	8	212	18965.2
27/05/2021	9	140	12442.79	7	70	6243
28/05/2021	1	26	2327	36	722	65117.04
31/05/2021	24	391	35375.29	17	339	30748.89
01/06/2021	20	486	43890.81	7	40	3632.4
02/06/2021	21	240	21442.51	4	109	9864.81
03/06/2021	23	617	54478.39	32	830	73730.89
04/06/2021	8	197	17514.11	29	450	40316.4
07/06/2021	19	419	37559.5	12	192	17305.59
08/06/2021	14	271	24327.81	15	413	37168.88
09/06/2021	7	242	21741.91	7	205	18450
10/06/2021	21	621	55478.77	13	225	20245.01
11/06/2021	22	500	44424.9	27	829	74156.62
14/06/2021	1	36	3247.2	21	454	41861.89
15/06/2021	7	178	16696.01	12	325	30676.59
16/06/2021	18	359	34060.99	18	365	34797.49
17/06/2021	21	567	53243.51	25	491	46319.81
18/06/2021	22	423	40053.79	19	510	48556.59
21/06/2021	27	665	62253.91	0	0	0
22/06/2021	16	385	35648.88	11	235	21793.99
23/06/2021	19	373	34307.2	3	80	7413
24/06/2021	5	133	12139.6	11	201	18445.01
25/06/2021	5	150	13865	20	549	50907.29
28/06/2021	6	54	5091.5	17	440	41647.01
29/06/2021	15	430	40596.3	11	390	36987.02
30/06/2021	27	743	69343.6	10	177	16588.9

Attachment

• PHARMAGEST_PRESSRELEASE_20210721_half-year report on the liquidity agreement_en_US